Related Experiment Videos
Cerivastatin: the low-dose HMG-COA reductase inhibitor
1Department of Medicine, Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland.
Expert Opinion on Investigational Drugs
|November 4, 2000
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Can LDL cholesterol be too low? Possible risks of extremely low levels.
Journal of internal medicine·2017
Rye bread intake improves oxidation resistance of LDL in healthy humans.
Atherosclerosis·2012
The effect of high-fiber rye bread enriched with nonesterified plant sterols on major serum lipids and apolipoproteins in normocholesterolemic individuals.
Nutrition, metabolism, and cardiovascular diseases : NMCD·2011
Hot flushes and biochemical markers for cardiovascular disease: a randomized trial on hormone therapy.
Climacteric : the journal of the International Menopause Society·2010
Peripheral cannabinoid-1 receptor antagonists in clinical development: therapeutic potential for the management of obesity and related metabolic disorders.
Expert opinion on investigational drugs·2026
Telisotuzumab adizutecan for metastatic colorectal cancer: a c-MET-targeted antibody-drug conjugate with a topoisomerase inhibitor payload.
Expert opinion on investigational drugs·2026
Taxane therapy in mCRPC: current positioning and emerging strategies to overcome resistance.
Expert opinion on investigational drugs·2026
Receptor interacting protein kinase 1 as a potential therapeutic target in inflammatory bowel disease: biological rationale and emerging clinical evidence.
Expert opinion on investigational drugs·2026
Budigalimab: a viable option for patients with advanced solid tumors.
Expert opinion on investigational drugs·2026
Cognitive-enhancing drugs in Phase II clinical trials for Alzheimer's disease: emerging therapeutic candidates.
Expert opinion on investigational drugs·2026
Broad-spectrum host-targeting antivirals for rhinovirus infections: mechanisms and future perspectives.
Frontiers in immunology·2026